Investing

Top Analyst Upgrades and Downgrades: Anthem, AEP, Apple, Broadcom, DocuSign, eBay, Gap, GameStop, Humana, Immunic, PG&E, Slack, Sysco and More

eBay Inc. (NASDAQ: EBAY) was reiterated as Hold but the price target was raised to $50 from $40 (versus a $49.38 close) at SunTrust Robinson Humphrey. BMO Capital Markets downgraded it to Market Perform from Outperform but raised its price target to$52 from $46.

Evolent Health Inc. (NYSE: EVH) was downgraded to Neutral from Buy and its price target was slashed to $8 from $13 (versus a $6.30 close) at Goldman Sachs. Its 52-week range is $3.50 to $12.01, and its consensus price target was $12.67.

Gap Inc. (NYSE: GPS) was reiterated as Neutral and its price target was raised to $12 from $8 at MKM Partners. Gap shares closed up 1.6% at $12.14 ahead of the calls, with an $8.87 consensus price target.

GameStop Corp. (NYSE: GME) closed up 0.7% at $4.47 on Thursday, and the shares were indicated down over 6% at $4.19 ahead of the open after its results were released earlier than expected. Credit Suisse reiterated it as Underperform and cut its price target to $3.50 from $4.50.

Hanesbrands Inc. (NYSE: HBI) was named as the Zacks Bear of the Day stock. The firm said that sales plunged in the first quarter but the new business is suspect. Shares last closed at $11.94 and have a consensus price target of $10.67.

Humana Inc. (NYSE: HUM) was started with a Buy rating and a $510 price target (versus a $392.27 close) at Goldman Sachs. It has a 52-week range of $208.25 to $412.70, and its consensus price target was $427.86.

Immunic Inc. (NASDAQ: IMUX) was started with an Outperform rating and a $59 price target (versus a $12.19 close) at Wedbush. The firm noted that the exponential upside potential attributed to the company’s target selectivity creates a best-in-class orally administered treatment candidates designed to treat chronic autoimmune, inflammatory and viral diseases. The stock has a 52-week range of $4.19 to $19.05, and its market cap was only $146 million as of Thursday’s close.

Macquarie Infrastructure Corp. (NYSE: MIC) was downgraded to Equal Weight from Overweight at Wells Fargo.

Meritage Homes Corp. (NYSE: MTH) was downgraded to In-Line from Outperform at Evercore ISI.

Navistar International Corp. (NYSE: NAV) was raised to Buy from Hold with a $35 price target (versus a $27.93 close) at Loop Capital. Robert W. Baird raised its rating to Outperform from Neutral with a $35 price target.

PG&E Corp. (NYSE: PCG) was raised to Buy from Neutral with a $14 price objective (versus an $11.87 close) at BofA Securities. It has a 52-week trading range of $3.55 to $25.19, and its consensus target price was $14.17.

REPAY Holdings Corp. (NASDAQ: RPAY) was reiterated as Buy and the price target was raised to $28 from $20 (versus a $23.67 close) at SunTrust Robinson Humphrey.

Slack Technologies Inc. (NYSE: WORK) closed down almost 5% at $37.94 on profit-taking ahead of earnings, and the shares were last seen down 13% at $33.00 after ahead of Friday’s open. Wedbush reiterated it as Underperform but raised its price target to $20 from $14.

Sysco Corp. (NYSE: SYY) was raised to Overweight from Equal Weight and the price target was raised to $70 from $50 at Wells Fargo. Shares closed down almost 1% at $58.59 ahead of the call, with a $55.14 consensus price target. They are still down from a 52-week high of $85.98.


With the current rally being considered a melt-up one that already was feeling extended (today’s gains not included), here are five sold dividend stocks from the team at BofA Securities for nervous investors.

Thursday’s top analyst upgrades and downgrades included Comerica, Costco, Caesars Entertainment, GameStop, Goldman Sachs, Plug Power, Replimune, Tyson Foods, Wells Fargo and more.